CD4 and neoplasm: In contrast, the depletion of CD4 and NK cells did not inhibit the antitumor activity of Vax/aGITR/aPD-1 therapy (Figure 5B) by day 25 post tumor implantation, indicating these cells played minor roles in the efficacy observed.